Vertex Pharmaceuticals Inc. reported fourth-quarter net income of $1.19 billion, or $4.65 per share, with adjusted earnings of $5.03 per share. This fell short of Wall Street’s expectation of $5.07 per share. Despite missing profit estimates, the company’s revenue of $3.19 billion surpassed forecasts.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vertex: Q4 Earnings Snapshot
Vertex Pharmaceuticals Inc. reported fourth-quarter net income of $1.19 billion, or $4.65 per share, with adjusted earnings of $5.03 per share. This fell short of Wall Street’s expectation of $5.07 per share. Despite missing profit estimates, the company’s revenue of $3.19 billion surpassed forecasts.